Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CRVS - Week In Review: Fosun Pharma Acquires Majority Stake In China Vaccine Company For $682 Million


CRVS - Week In Review: Fosun Pharma Acquires Majority Stake In China Vaccine Company For $682 Million

  • Shanghai Fosun Pharma announced a $628 million deal to acquire a 73% stake in vaccine company Chengdu Antejin Biotech.
  • Shanghai Pharma subsidiary SPH SINE acquired greater China rights for two microbiome therapies from Korea's KoBioLabs in a $110 million deal.
  • Suzhou Innovent and Shenzhen NeoCura will test a combination of Innovent's PD-1, sintilimab, and NeoCura's individual neoantigen mRNA vaccine in patients with solid tumor cancers.

For further details see:

Week In Review: Fosun Pharma Acquires Majority Stake In China Vaccine Company For $682 Million
Stock Information

Company Name: Corvus Pharmaceuticals Inc.
Stock Symbol: CRVS
Market: NASDAQ
Website: corvuspharma.com

Menu

CRVS CRVS Quote CRVS Short CRVS News CRVS Articles CRVS Message Board
Get CRVS Alerts

News, Short Squeeze, Breakout and More Instantly...